Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study

J Dtsch Dermatol Ges. 2010 Mar;8(3):174-8. doi: 10.1111/j.1610-0387.2009.07293.x. Epub 2009 Nov 2.
[Article in English, German]

Abstract

Background: Actinic keratoses (AK) are carcinomas in situ and can progress to invasive squamous cell carcinomas. Treatment of actinic keratoses can be achieved by physical ablation, chemotherapeutic agents, immunomodulators or photodynamic therapy.

Patients and methods: We conducted a proof of concept study with 15 patients. Overall 66 actinic keratoses were treated with 5-FU (0.5%) and salicylic acid (10%) for 4 weeks (3 times per week).

Results: After 12 weeks complete response of 47 AK (77%), partial response of 13 AK (21%) and non-response of 1 AK (2%) were achieved.

Conclusions: Treatment was well tolerated and efficient.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Infective Agents / administration & dosage
  • Drug Combinations
  • Female
  • Fluorouracil / administration & dosage*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Keratosis, Actinic / drug therapy*
  • Keratosis, Actinic / pathology
  • Male
  • Middle Aged
  • Pilot Projects
  • Salicylic Acid / administration & dosage*
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Drug Combinations
  • Immunosuppressive Agents
  • Salicylic Acid
  • Fluorouracil